Latest Insmed News & Updates

See the latest news and media coverage for Insmed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Insmed

Biopharmaceutical company developing therapies for serious diseases

insmed.com
Headquarters
Bridgewater Township, United States
Company type
Public company
Number of employees
1,700–5,000

Last updated

Latest news about Insmed

In short: Insmed achieved regulatory approvals for Brinsupri and reported robust revenue growth, despite facing clinical setbacks in its brensocatib program.

Company announcements

Insmed

Insmed reports Q1 2026 financial results

Total revenues reach $306M with BRINSUPRI at $207.9M and ARIKAYCE at $98.1M. Reiterates 2026 guidance. ENCORE study meets endpoints; PALM-PAH initiated.

Insmed

Insmed announces CEDAR study fails endpoints

Insmed discontinues brensocatib HS program. Safety consistent with prior studies, no new signals. Data shows placebo outperformed treatment arms.

Unlock all announcements with a

Media coverage

GuruFocus

Insmed (INSM) Sees Price Target Reduction Amid Market Sentiment

On June 15, 2026, Mizuho revised its price target for Insmed INSM, lowering it to $192 from the previous $202 while maintaining an Outperform rating...

Unlock all articles with a

Never miss news about Insmed

Track Insmed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Insmed competitors & trending companies

Browse news for competitors to Insmed and other trending companies.